Previous 10 | Next 10 |
COLLEGE STATION, TX / ACCESSWIRE / July 21, 2023 / Enzolytics, Inc. (OTC PINK:ENZC) ( https://enzolytics.com/ ). Biogenysis, Inc. ("BGEN"), a wholly owned subsidiary of Enzolytics, Inc. (the "Company" or "ENZC"), a drug development biotech company, announced today a partnership with Khalpey AI ...
COLLEGE STATION, TX / ACCESSWIRE / July 11, 2023 / Enzolytics, Inc. (OTC PINK:ENZC) (https://enzolytics.com/). Enzolytics, Inc. ("ENZC" or the "Company") filed a Supplemental Information report today to provide additional details regarding the recently entered non-binding letter of intent with ...
ALLEN, TX / ACCESSWIRE / July 6, 2023 / Enzolytics, Inc. (OTC PINK:ENZC) ( https://enzolytics.com/ ). Virogentics, Inc. ("VIRO") a wholly owned subsidiary of Enzolytics, Inc. (the "Company" or "ENZC"), a drug development biotech company, announced today its plan to introduce a dietary supplemen...
COLLEGE STATION, TX / ACCESSWIRE / June 29, 2023 / Enzolytics, Inc. (OTC PINK:ENZC) (https://enzolytics.com/). Enzolytics, Inc. (the "Company" or "ENZC"), a drug development biotech company, and Sagaliam Acquisition Corp. (NASDAQ:SAGA) ("Sagaliam") (together the "Parties") announced today they ...
COLLEGE STATION, TX / ACCESSWIRE / June 26, 2023 / Enzolytics, Inc. (OTC PINK:ENZC) ( https://enzolytics.com/ ). Enzolytics, Inc. (the "Company" or "ENZC"), a drug development biotech company, today provided an update regarding Virogentics, Inc.'s ("VIRO") ITV-1 African Project. The final prot...
COLLEGE STATION, TX / ACCESSWIRE / June 5, 2023 / Enzolytics, Inc. (OTC PINK:ENZC) ( https://enzolytics.com/ ). Enzolytics, Inc. (the "Company" or "ENZC"), a drug development biotech company, today provided updates regarding the sale of Virogentics, Inc. ("VIRO") and Biogenysis, Inc. to Sagalia...
COLLEGE STATION, TX / ACCESSWIRE / May 19, 2023 / Enzolytics, Inc. (OTC PINK:ENZC) ( https://enzolytics.com/ ) Enzolytics wants to inform its shareholders that the ownership of the Company's patented technology is held exclusively in the name of The Zhabilov Trust, with Diana Zhabilov serving as...
COLLEGE STATION, TX / ACCESSWIRE / May 16, 2023 / Enzolytics, Inc. (OTC PINK:ENZC) ( https://enzolytics.com/ ). Enzolytics, Inc. (the "Company" or "ENZC"), a drug development biotech company, announced that the Company's wholly owned subsidiary, Virogentics (VIRO), has received the analysis repo...
COLLEGE STATION, TX / ACCESSWIRE / December 13, 2022 / Enzolytics, Inc. (OTC PINK:ENZC) ( https://enzolytics.com/ ). Enzolytics' focus is on the production and distribution of the Company's therapeutics and advancing its research and development programs. The Company sees the coming year as a t...
COLLEGE STATION, TX / ACCESSWIRE / December 1, 2022 / Enzolytics, Inc. (OTC PINK:ENZC) ( https://enzolytics.com/ ). World AIDS Day has been recognized on this day since 1988. It is an important day for the world to reflect on those who have been lost in the HIV pandemic and recommit to the chal...
News, Short Squeeze, Breakout and More Instantly...
Update on Sagaliam Acquisition Corp. ALLEN, TX / ACCESSWIRE / July 1, 2024 / Enzolytics, Inc. (OTC PINK:ENZC) (" enzolytics.com ") (the "Company") announced today that the Company is entering into a worldwide exclusive licensing agreement for US Patent # 8067531-B2, "Inactivated pepsin frag...
ALLEN, TX / ACCESSWIRE / June 3, 2024 / Enzolytics, Inc. (OTC PINK:ENZC) ("enzolytics.com")(the "Company") is thrilled to announce that the Company and Sagaliam Acquisition Corp ("SAGA") are negotiating a landmark investment of six million US dollars ($6,000,000). This investment includes three ...
Updates on ETC Marketing, Inc and Ownership of ITV-1 and IPF ALLEN, TX / ACCESSWIRE / May 22, 2024 / Enzolytics, Inc. (OTC PINK:ENZC) (" enzolytics.com " )(the "Company") announced today that it has entered into a Letter of Intent with Enogenesis (ENGN) for the specific use of the therape...